O

OssDsign AB
STO:OSSD

Watchlist Manager
OssDsign AB
STO:OSSD
Watchlist
Price: 15.22 SEK 2.7% Market Closed
Market Cap: 1.7B SEK
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one OSSD stock under the Base Case scenario is 14.36 SEK. Compared to the current market price of 15.22 SEK, OssDsign AB is Overvalued by 6%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

OSSD Relative Value
Base Case
14.36 SEK
Overvaluation 6%
Relative Value
Price
O
Worst Case
Base Case
Best Case

Valuation Multiples

11
P/S
P/S
Price to Sales
11
vs History
50
vs Industry
15
Median 3Y
8.1
Median 5Y
10.8
Industry
2.3
Forward
8.9
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-6.9
Median 5Y
-8.6
Industry
22.3
Forward
-35.8
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-8.8
Median 5Y
-10.4
Industry
14.2
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-8.6
Median 5Y
-9
Industry
20
More Details
8.2
P/B
P/B
Price to Book Value
8.2
vs History
19
vs Industry
14
Median 3Y
3.4
Median 5Y
3.6
Industry
2.2
More Details
10.5
EV/S
EV/S
Enterprise Value to Sales
10.5
vs History
41
vs Industry
16
Median 3Y
7.2
Median 5Y
9.3
Industry
2.5
Forward
8.5
More Details
10.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.9
vs History
53
vs Industry
27
Median 3Y
8.5
Median 5Y
12
Industry
5.1
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-6.6
Median 5Y
-8.1
Industry
11.7
Forward
-47.8
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-6.6
Median 5Y
-8.1
Industry
16.1
Forward
-41.7
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-7.5
Median 5Y
-8.6
Industry
14.3
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-7.4
Median 5Y
-8.6
Industry
17.8
More Details
7.8
EV/IC
EV/IC
Enterprise Value to IC
7.8
vs History
9
vs Industry
16
Median 3Y
3.3
Median 5Y
4.2
Industry
1.9
More Details

Multiples Across Competitors

OSSD Competitors Multiples
OssDsign AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
OssDsign AB
STO:OSSD
1.7B SEK 11 -31.3 -31.6 -31.6
CH
Alcon AG
SIX:ALC
35.5B CHF 4.4 39 17.9 33.9
JP
Hoya Corp
TSE:7741
6T JPY 7 29.9 18.4 22
DK
Coloplast A/S
CSE:COLO B
133.7B DKK 4.8 29.4 17 20.1
US
Align Technology Inc
NASDAQ:ALGN
10B USD 2.5 24.5 11.3 13.9
CH
Ypsomed Holding AG
SIX:YPSN
5.4B CHF 7.2 61.2 29.5 50.4
UK
ConvaTec Group PLC
LSE:CTEC
4.8B GBP 2.7 29.2 224 364
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.6B CNY 12.1 30.6 26.3 26.3
US
Merit Medical Systems Inc
NASDAQ:MMSI
5B USD 3.6 41 19 33.3
US
Lantheus Holdings Inc
NASDAQ:LNTH
4.9B USD 3.2 19.2 8.7 9.9
CA
Bausch + Lomb Corp
NYSE:BLCO
4.8B USD 1 -13.2 16.8 73.8
P/E Multiple
Earnings Growth PEG
SE
O
OssDsign AB
STO:OSSD
Average P/E: 33.8
Negative Multiple: -31.3 		N/A N/A
CH
Alcon AG
SIX:ALC
39
28%
1.4
JP
Hoya Corp
TSE:7741
29.9
N/A N/A
DK
Coloplast A/S
CSE:COLO B
29.4
14%
2.1
US
Align Technology Inc
NASDAQ:ALGN
24.5
30%
0.8
CH
Ypsomed Holding AG
SIX:YPSN
61.2
N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
29.2
33%
0.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
30.6
20%
1.5
US
Merit Medical Systems Inc
NASDAQ:MMSI
41
27%
1.5
US
Lantheus Holdings Inc
NASDAQ:LNTH
19.2
25%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -13.2 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
O
OssDsign AB
STO:OSSD
Average EV/EBITDA: 38.9
Negative Multiple: -31.6 		N/A N/A
CH
Alcon AG
SIX:ALC
17.9
10%
1.8
JP
Hoya Corp
TSE:7741
18.4
9%
2
DK
Coloplast A/S
CSE:COLO B
17
9%
1.9
US
Align Technology Inc
NASDAQ:ALGN
11.3
15%
0.8
CH
Ypsomed Holding AG
SIX:YPSN
29.5
N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
224
11%
20.4
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
26.3
18%
1.5
US
Merit Medical Systems Inc
NASDAQ:MMSI
19
12%
1.6
US
Lantheus Holdings Inc
NASDAQ:LNTH
8.7
21%
0.4
CA
Bausch + Lomb Corp
NYSE:BLCO
16.8
19%
0.9

See Also

Summary
OSSD intrinsic value, competitors valuation, and company profile.
DCF Valuation
OSSD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
OSSD stock valuation using valuation multiples.
Wall Street Estimates
OSSD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
OSSD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 271,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.